AHA urged CMS to “avoid unintended consequences” affecting the 340B program in public comments on the agency's plan to implement the Medicare Drug Price Negotiation Program.

AHA Urges CMS to Consider 340B When Implementing MDPNP, PhRMA Warns Against ‘Price Setting’

A key national hospital trade group recently called on CMS leaders to “avoid unintended consequences” affecting the 340B program—and the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live